Mycobacterium tuberculosis is the bacteria that causes tuberculosis. TB germs are most commonly found in the lungs, although they can also be found in the kidney, spine, and brain. Latent tuberculosis infection (LTBI) and tuberculosis illness are two TB-related diseases. The Bacille Calmette-Guérin (BCG) vaccination is used to prevent tuberculosis (TB). In the U.S., this vaccine is not extensively utilized. It is, nevertheless, frequently given to newborns and small children in other countries where tuberculosis is prevalent. The BCG vaccine does not always protect people from contracting tuberculosis. Pediatric tuberculosis is a public health problem of particular importance since it is a marker of recent transmission of tuberculosis.
Market Dynamics
Increasing awareness for prevention of tuberculosis is expected to drive growth of the global human tuberculosis vaccine market during the forecast period. For instance, in March 2022, Johnson & Johnson Philippines Inc., a subsidiary of Johnson & Johnson, and the Philippine Tuberculosis Society Inc. (PTSI), a non-profit, nongovernment organization, rolled out their joint priority project in 2022, a campaign to find the ‘missing millions’ affected by tuberculosis (TB) among the country's youth and help them improve their lung health with the right treatment
Increasing government initiatives to combat tuberculosis is expected to drive the market growth of global human tuberculosis vaccine market. For instance, in March 2018, the Ministry of Health and Prevention, MOHAP, organized an event in observation of World Tuberculosis Day, under the slogan ‘We need leaders to create a world free from tuberculosis’. The event was held to create awareness about the seriousness of tuberculosis and identify its symptoms and ways of transmission.
Key features of the study:
- This report provides an in-depth analysis of the global human tuberculosis vaccine market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global human tuberculosis vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
- Key companies covered as a part of this study include GlaxoSmithKline Plc, Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Valneva SE, Archivel Farma, BIOFABRI (Zendal), Japan BCG Laboratory, GreenSignal Bio Pharma Private Limited (GSBPL), AJ Vaccines A/S, Taj Pharma India Limited, and Biomed Lublin S.A.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global human tuberculosis vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have an ease in decision-making through various strategy matrices used in analyzing the global human tuberculosis vaccine market
Detailed Segmentation:
- Global Human Tuberculosis Vaccine Market, by Route of Administration :
- Global Human Tuberculosis Vaccine Market, by Age Group :
- Global Human Tuberculosis Vaccine Market, by Distribution Channel :
- Global Human Tuberculosis Vaccine Market, By Region:
- North America
- Latin America
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Country:
- Australia
- India
- China
- Japan
- ASEAN
- South Korea
- Rest of Asia Pacific
- Middle East
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- GlaxoSmithKline Plc *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Serum Institute of India Pvt. Ltd.
- Valneva SE
- Archivel Farma
- BIOFABRI (Zendal)
- Japan BCG Laboratory
- GreenSignal Bio Pharma Private Limited (GSBPL)
- AJ Vaccines A/S
- Taj Pharma India Limited
- Biomed Lublin S.A.
“*” marked represents similar segmentation in other categories in the respective section.